Legal Representation
Attorney
Andrew N. Fredbeck
USPTO Deadlines
Next Deadline
1239 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20230613)
Due Date
June 13, 2029
Grace Period Ends
December 13, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
41 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 9, 2023 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Sep 14, 2023 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Sep 14, 2023 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Sep 13, 2023 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Jun 13, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jun 13, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 29, 2023 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Mar 28, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 28, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 8, 2023 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Mar 8, 2023 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Mar 8, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 21, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 18, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 17, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 17, 2023 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Oct 31, 2022 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Oct 12, 2022 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Oct 12, 2022 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Aug 26, 2022 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Aug 26, 2022 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Aug 26, 2022 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Aug 3, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 2, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 2, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 2, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 2, 2022 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 2, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 2, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 1, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 1, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 27, 2021 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Jun 1, 2021 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Jun 1, 2021 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| May 27, 2021 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| May 26, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 18, 2021 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| May 14, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 14, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 13, 2021 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED | Loading... |
| May 8, 2021 | SDRC | M | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for use in treating gynecological and urological diseases and disorders; pharmaceutical preparations for treating ailments caused by radiation or chemotherapy; medical preparations for use in treating gynecological and urological diseases and disorders; medical preparations for treating ailments caused by radiation or chemotherapy; medicinal preparations for use in treating gynecological and urological diseases and disorders; medicinal preparations for treating ailments caused by radiation or chemotherapy; pharmaceutical substances for use in treating gynecological and urological diseases and disorders; medicated food supplements
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
syringes for injections; apparatus for irrigation of liquids for medical use; syringes and cannulas for medical use
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
010
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"CYST"